CINGULATE INC (CING) Stock Price, Quote, News and Overview
NASDAQ:CING - Nasdaq - US17248W3034 - Common Stock - Currency: USD
CING Quote, Performance and Key Statistics
CINGULATE INC
NASDAQ:CING (1/23/2025, 12:48:09 PM)
5.06
+0.03 (+0.6%)
The current stock price of CING is 5.06 USD. In the past month the price increased by 22.68%. In the past year, price decreased by -88.7%.
CING Latest News, Press Releases and Analysis
Final Study Completed for Cingulate’s Lead Asset CTx-1301
No Serious Adverse Events ReportedSubmission of New Drug Application Targeted for Mid 2025 KANSAS CITY, Kan., Jan. 07, 2025 (GLOBE NEWSWIRE) --...
Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
Cash Runway Extended Beyond Planned NDA Submission of CTx-1301...
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
On Target for Mid-2025 New Drug Application (NDA) Submission of lead ADHD asset CTx-1301...
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company...
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
$10 Million of additional Capital Recently Raised Strengthening Balance Sheet...
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.
CING Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 75.02 | 724.25B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.38 | 362.37B | ||
| JNJ | JOHNSON & JOHNSON | 14.66 | 352.60B | ||
| MRK | MERCK & CO. INC. | 16.25 | 244.57B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.99 | 212.55B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.36 | 199.21B | ||
| PFE | PFIZER INC | 10.17 | 148.70B | ||
| SNY | SANOFI-ADR | 12.39 | 130.14B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 49.76 | 118.09B | ||
| ZTS | ZOETIS INC | 28.86 | 75.01B | ||
| GSK | GSK PLC-SPON ADR | 8.25 | 69.33B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.53 | 40.96B |
Related screens
About CING
Company Profile
Cingulate Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Kansas City, Kansas and currently employs 13 full-time employees. The company went IPO on 2021-10-07. Cingulate Inc. is a biopharmaceutical company. The firm is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. The company focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The firm is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.
Company Info
CINGULATE INC
1901 W. 47Th Place
Kansas City KANSAS US
Employees: 13
Company Website: https://www.cingulate.com/
Investor Relations: https://www.cingulate.com/investors
Phone: 19139422300
CING FAQ
What is the price of CING?
The current price of CING is 5.06 USD.
What is the symbol for CINGULATE INC?
The exchange symbol of CINGULATE INC is CING and it is listed on the Nasdaq exchange.
On which exchange is CING listed?
CING is listed on the Nasdaq exchange.
Is CING a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CING, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CING.
Does CING pay dividends?
CING does not pay a dividend.
What is the Price/Earnings (PE) ratio of CING?
CING does not have a PE ratio as the earnings reported over the last twelve months were negative (-106.42).
What is the Short Interest ratio of CING?
The outstanding short interest for CING is 3.65% of its float.
CING Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CING. When comparing the yearly performance of all stocks, CING is a bad performer in the overall market: 93.15% of all stocks are doing better.
CING Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CING. CING scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CING Financial Highlights
Over the last trailing twelve months CING reported a non-GAAP Earnings per Share(EPS) of -106.42. The EPS increased by 72.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -120.39% | ||
| ROE | -135.81% | ||
| Debt/Equity | 0 |
CING Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to CING. The Buy consensus is the average rating of analysts ratings from 10 analysts.